| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.02260-10 |
| P8608 | Fatcat ID | release_xpjt2j72jrekvjoucffley5q2u |
| P932 | PMC publication ID | 3067923 |
| P698 | PubMed publication ID | 21191015 |
| P50 | author | Cornelia C. Bergmann | Q55426323 |
| Timothy W Phares | Q117769739 | ||
| Stephen A Stohlman | Q117769757 | ||
| P2093 | author name string | David R Hinton | |
| Cristina P Marques | |||
| P2860 | cites work | A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines | Q24315971 |
| BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 | ||
| Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 | Q24647146 | ||
| A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) | Q24677007 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo | Q28143201 | ||
| BAFFled B cells survive and thrive: roles of BAFF in B-cell development | Q28204272 | ||
| A critical role for IL-21 in regulating immunoglobulin production | Q28215868 | ||
| APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells | Q28263864 | ||
| Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation | Q28270256 | ||
| Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia | Q28581828 | ||
| BCMA is essential for the survival of long-lived bone marrow plasma cells | Q28587037 | ||
| The many roles of chemokines and chemokine receptors in inflammation | Q29618880 | ||
| Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies | Q30851947 | ||
| Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells | Q33440567 | ||
| RNase L mediated protection from virus induced demyelination | Q33508237 | ||
| The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. | Q33508816 | ||
| Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation | Q33599648 | ||
| IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism | Q33656121 | ||
| IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses | Q33656146 | ||
| Role of viral persistence in retaining CD8(+) T cells within the central nervous system | Q33810508 | ||
| Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis | Q33826812 | ||
| Interleukin-6 expression and regulation in astrocytes | Q33850723 | ||
| Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. | Q34018474 | ||
| Extrafollicular antibody responses | Q34212117 | ||
| Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection | Q34471390 | ||
| A fundamental role for interleukin-21 in the generation of T follicular helper cells | Q34792475 | ||
| Control of central nervous system viral persistence by neutralizing antibody | Q34859605 | ||
| Traffic patterns of B cells and plasma cells. | Q34982807 | ||
| BAFF AND APRIL: a tutorial on B cell survival | Q34994661 | ||
| Immune responses to RNA-virus infections of the CNS. | Q35140815 | ||
| Homing of antibody secreting cells | Q35170914 | ||
| Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF | Q35755470 | ||
| Regulation of plasma-cell development | Q36058417 | ||
| Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). | Q36353962 | ||
| A coordinated change in chemokine responsiveness guides plasma cell movements | Q36369352 | ||
| Coronavirus infection of the central nervous system: host-virus stand-off | Q36369843 | ||
| Stromal niches, plasma cell differentiation and survival. | Q36450001 | ||
| TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties | Q37178196 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| APRIL in B-cell malignancies and autoimmunity | Q37367983 | ||
| IL-21: an executor of B cell fate | Q37388253 | ||
| IL-21 and T follicular helper cells | Q37481635 | ||
| BAFF: a local and systemic target in autoimmune diseases | Q37593590 | ||
| Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum | Q37757179 | ||
| Peptidoglycan induces interleukin‐6 expression through the TLR2 receptor, JNK, c‐Jun, and AP‐1 pathways in microglia | Q39644376 | ||
| TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts | Q40066472 | ||
| A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis | Q40185060 | ||
| Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation | Q40891679 | ||
| Antibody prevents virus reactivation within the central nervous system | Q41670143 | ||
| Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. | Q41689082 | ||
| IgG subclass responses in brain and serum in Semliki Forest virus demyelinating encephalitis | Q42079051 | ||
| TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens | Q43596939 | ||
| Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system | Q43684853 | ||
| Intrathecal antibody production in an animal model of multiple sclerosis | Q44091072 | ||
| Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. | Q44683768 | ||
| Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells. | Q45419308 | ||
| Interleukin-21 mRNA expression during virus infections | Q45420919 | ||
| Semliki Forest virus-induced demyelination and remyelination--involvement of B cells and anti-myelin antibodies | Q45728524 | ||
| Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus | Q45798882 | ||
| Virus titres and persistently raised white cell counts in cerebrospinal fluid in mice after peripheral infection with demyelinating Semliki Forest virus | Q45799215 | ||
| Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis | Q46106385 | ||
| CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. | Q46275246 | ||
| IFN-gamma is required for viral clearance from central nervous system oligodendroglia | Q46323621 | ||
| Regulation of matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) genes during JHMV infection of the central nervous system. | Q46622478 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Long term intraparenchymal Ig secretion after acute viral encephalitis in mice | Q48394895 | ||
| Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. | Q50550577 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature. | Q51833354 | ||
| Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. | Q51966554 | ||
| Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. | Q52950179 | ||
| Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. | Q52956500 | ||
| B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. | Q54707196 | ||
| Regulation of Homeostatic Chemokine Expression and Cell Trafficking During Immune Responses | Q57227496 | ||
| BAFF is a survival and maturation factor for mouse B cells | Q74456240 | ||
| The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity | Q78346721 | ||
| Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody | Q81404086 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2589-2598 | |
| P577 | publication date | 2010-12-29 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Factors supporting intrathecal humoral responses following viral encephalomyelitis | |
| P478 | volume | 85 |
| Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
| Q52680802 | Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses. |
| Q36667911 | Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis |
| Q35826089 | CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q35077540 | CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis |
| Q92712543 | Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis |
| Q59354509 | Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease |
| Q64957483 | Clinical utility of a molecular signature in inflammatory demyelinating disease. |
| Q55376062 | Distinct Gene Profiles of Bone Marrow-Derived Macrophages and Microglia During Neurotropic Coronavirus-Induced Demyelination. |
| Q36535632 | Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis. |
| Q36919822 | Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection |
| Q38617794 | IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. |
| Q37228165 | IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis |
| Q37547551 | Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages |
| Q38272285 | Immune responses to non-tumor antigens in the central nervous system. |
| Q40527857 | Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis |
| Q34277052 | Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis |
| Q38084075 | Intrathecal humoral immunity to encephalitic RNA viruses. |
| Q37342611 | MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis. |
| Q35216111 | MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. |
| Q95660583 | Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system |
| Q36173898 | Oligodendroglia are limited in type I interferon induction and responsiveness in vivo |
| Q31050845 | Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus |
| Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
| Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
| Q36607157 | Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis |
| Q35708880 | T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease |
| Q38601694 | The Role of BAFF System Molecules in Host Response to Pathogens |
| Q36468266 | The chemokine receptor CXCR2 and coronavirus-induced neurologic disease |
| Q90079316 | To Go or Stay: The Development, Benefit, and Detriment of Tissue-Resident Memory CD8 T Cells during Central Nervous System Viral Infections |
| Q36117017 | Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis |
Search more.